NCT00492713

Brief Summary

Dark chocolate is one of the richest sources of polyphenols though it has been hypothesised that the bioavailability of epicatechin from milk chocolate was reduced compared to dark. The primary outcome measure is to compare plasma polyphenol levels after consumption of 3 chocolates (2 milk, 1 dark) while the secondary outcome measures are to characterise the time course of polyphenols in the blood and to investigate individual variation in Tmax and Cmax for use in future studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Jun 2007

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2007

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

June 25, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 27, 2007

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
3.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

March 29, 2013

Status Verified

March 1, 2013

Enrollment Period

1.3 years

First QC Date

June 25, 2007

Last Update Submit

March 27, 2013

Conditions

Keywords

BioavailabilityDark ChocolateMilk ChocolatePolyphenols

Outcome Measures

Primary Outcomes (1)

  • AUC plasma polyphenols

    24 hours

Secondary Outcomes (2)

  • Tmax and Cmax of plasma polyphenols

    24 hours

  • Plasma and urinary metabolite identification and quantification

    24 hours

Study Arms (3)

1

ACTIVE COMPARATOR

Dark chocolate

Other: dark chocolate

2

ACTIVE COMPARATOR

Milk chocolate 1

Other: Milk chocolate 1

3

ACTIVE COMPARATOR

Milk chocolate 2

Other: Milk chocolate 2

Interventions

dark chocolate

1

Milk chocolate 1

2

Milk chocolate 2

3

Eligibility Criteria

Age19 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years, male and female
  • Healthy as determined by the medical questionnaire
  • Normal weight: BMI 19 - 25
  • Having given informed consent

You may not qualify if:

  • Intestinal or metabolic diseases/disorders such as diabetic, renal, hepatic, hypertension, pancreatic or ulcer, including lacto-intolerance.
  • Have had a major gastrointestinal surgery.
  • Have a regular consumption of medication.
  • Have an exceptionally high intake of chocolate or similarly high polyphenol foods.
  • Have a high and regular intake of vitamin supplements
  • Have an alcohol intake: \> 2 units a day
  • Patient who cannot be expected to comply with treatment.
  • Smoker
  • Having a nut allergy
  • Unwilling to consume chocolate
  • Currently participating or having participated in another clinical trial during the last 3 weeks.
  • Having given blood in the past three weeks
  • More than 3 x 45 min of exercise per week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nestle Research Center

Lausanne, Canton of Vaud, 1000, Switzerland

Location

Related Publications (1)

  • Serafini M, Bugianesi R, Maiani G, Valtuena S, De Santis S, Crozier A. Plasma antioxidants from chocolate. Nature. 2003 Aug 28;424(6952):1013. doi: 10.1038/4241013a. No abstract available.

    PMID: 12944955BACKGROUND

Study Officials

  • Karen A Cooper, PhD

    Société des Produits Nestlé (SPN)

    PRINCIPAL INVESTIGATOR
  • Gary Williamson, PhD

    Société des Produits Nestlé (SPN)

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2007

First Posted

June 27, 2007

Study Start

June 1, 2007

Primary Completion

September 1, 2008

Study Completion

April 1, 2012

Last Updated

March 29, 2013

Record last verified: 2013-03

Locations